Latest Financials News

Next Science Limited is set to distribute approximately A$0.145 per share following the sale of its assets to OSARTIS GmbH, marking a significant step towards winding down its operations.

Bioxyne Limited has reported a record $17.2 million in quarterly revenue, driven by strong growth in its cannabis and psychedelics segments, alongside strategic international expansions including a Frankfurt dual listing and new manufacturing agreements.

Dubber Corporation Limited has signed a significant five-year contract with a major North American communications provider, while trimming costs and targeting operating cashflow breakeven in FY26.

Enegex Limited has reported promising gold exploration results in Côte d’Ivoire and Western Australia, supported by a $5 million capital raise and strategic board appointments.

Altitude Minerals has bolstered its exploration portfolio with strategic acquisitions in Nevada and New South Wales, commencing extensive drilling programs while maintaining a solid cash position of $1.9 million.

Scalare Partners reported a remarkable 231% revenue increase in Q2 FY26, driven by full integration of recent acquisitions and new ecosystem initiatives. The company also turned operating cashflow positive, signalling strong momentum ahead.

Greatland Resources capped off 2025 with robust gold and copper production at Telfer, generating $406 million in operating cash flow, while its Havieron feasibility study confirmed a world-class, low-cost gold-copper mine with a $4.2 billion pre-tax NPV.

Develop Global Limited reports strong December quarter progress with Woodlawn mine commissioning on track, a major contract win, and a significant value uplift at Sulphur Springs ahead of a mid-2026 investment decision.

Ragusa Minerals has raised $600,000 through a private placement to fund exploration at its Purple Pansy Manganese-Gold Project in Arizona, supported strongly by existing shareholders.

LTR Pharma has marked a key milestone with over 1,000 SPONTAN prescriptions under Australia’s Special Access Scheme and is advancing clinical trials and US market preparations for its erectile dysfunction treatments.

Ampol Limited reports a robust fourth quarter Lytton Refiner Margin of US$15.14 per barrel, underpinning a strong preliminary FY25 earnings update with an expected EBIT of approximately $945 million.

Control Bionics has raised $3.8 million to fuel growth, forged a key distribution deal with Tobii, and integrated with Apple’s BCI protocol, while advancing its NeuroStrip and NeuroBounce platforms.